Page 31 - e-book CPG - Bipolar Disorder

P. 31

CLINICAL PRACTICE GUIDELINES MANAGEMENT OF BIPOLAR DISORDER (2ND ED.)

b.
Repetitive transcranial magnetic stimulation
b. Repetitive transcranial magnetic stimulation
A meta-analysis on adults with bipolar depression comparing repetitive transcranial magnetic
Repetitive transcranial magnetic stimulation
b.
A meta-analysis on adults with bipolar depression comparing repetitive transcranial magnetic
stimulation (rTMS) with sham treatment showed
Repetitive transcranial magnetic stimulation that the former was more effective in
b.
A meta-analysis on adults with bipolar depression comparing repetitive transcranial magnetic
Repetitive transcranial magnetic stimulation that the former was more effective in
b.
stimulation (rTMS) with sham treatment showed
achieving clinical response as measured by HAM-D or MADRS (OR=2.72, 95% CI 1.44 to
A meta-analysis on adults with bipolar depression comparing repetitive transcranial magnetic
stimulation (rTMS) with sham treatment showed that the former was more effective in
A meta-analysis on adults with bipolar depression comparing repetitive transcranial magnetic
achieving clinical response as measured by HAM-D or MADRS (OR=2.72, 95% CI 1.44 to
stimulation (rTMS) with sham treatment showed that the former was more effective in
5.14). In terms of safety, there was only one case of hypomania and one case of mania.
achieving clinical response as measured by HAM-D or MADRS (OR=2.72, 95% CI 1.44 to
stimulation (rTMS) with sham treatment showed that the former was more effective in
5.14). In terms of safety, there was only one case of hypomania and one case of mania.
Majority of the primary papers had low RoB.

60, level I
achieving clinical response as measured by HAM-D or MADRS (OR=2.72, 95% CI 1.44 to
5.14). In terms of safety, there was only one case of hypomania and one case of mania.
achieving clinical response as measured by HAM-D or MADRS (OR=2.72, 95% CI 1.44 to
60, level I

Majority of the primary papers had low RoB.

5.14). In terms of safety, there was only one case of hypomania and one case of mania.
60, level I

Majority of the primary papers had low RoB.

5.14). In terms of safety, there was only one case of hypomania and one case of mania.
A systematic review on adults with BD found that:

60, level I 61, level I

Majority of the primary papers had low RoB.

A systematic review on adults with BD found that:
60, level I 61, level I
Majority of the primary papers had low RoB.

 left rTMS, when compared with sham treatment, was more effective in improving

A systematic review on adults with BD found that:
61, level I

 left rTMS, when compared with sham treatment, was more effective in improving

working memory and processing speed
61, level I

A systematic review on adults with BD found that: but not in reducing depressive or manic
A systematic review on adults with BD found that: treatment, was more effective in improving
 left rTMS, when compared with sham
61, level I
working memory and processing speed but not
in reducing depressive or manic
 left rTMS, when compared with sham treatment, was more effective in improving
symptoms while side effects were comparable between the two groups
working memory and processing speed but not in reducing depressive or manic
 left rTMS, when compared with sham treatment, was more effective in improving
symptoms while side effects were comparable between the two groups
 right rTMS, when compared with sham treatment, was more effective in reducing HAM-
working memory and processing speed but not in reducing depressive or manic
symptoms while side effects were comparable between the two groups
working memory and processing speed but not in reducing depressive or manic
 right rTMS, when compared with sham treatment, was more effective in reducing HAM-
D scores at two weeks post-treatment but conflicting results in its effectiveness in mania
symptoms while side effects were comparable between the two groups
 right rTMS, when compared with sham treatment, was more effective in reducing HAM-
D scores at two weeks post-treatment but conflicting results in its effectiveness in mania
symptoms while side effects were comparable between the two groups
 right rTMS, when compared with sham treatment, was more effective in reducing HAM-
 right rTMS and left rTMS showed similar response and remission rates in depressive
D scores at two weeks post-treatment but conflicting results in its effectiveness in mania
 right rTMS, when compared with sham treatment, was more effective in reducing HAM-
 right rTMS and left rTMS showed similar response and remission rates in depressive
D scores at two weeks post-treatment but conflicting results in its effectiveness in mania
episodes
 right rTMS and left rTMS showed similar response and remission rates in depressive
D scores at two weeks post-treatment but conflicting results in its effectiveness in mania
episodes
 bilateral rTMS was more effective than right rTMS in proportion of responders but equally
 right rTMS and left rTMS showed similar response and remission rates in depressive
episodes
 right rTMS and left rTMS showed similar response and remission rates in depressive
 bilateral rTMS was more effective than right rTMS in proportion of responders but equally
effective in remission rates in depressive episodes
episodes
 bilateral rTMS was more effective than right rTMS in proportion of responders but equally
episodes
effective in remission rates in depressive episodes
The RoB of the primary papers was heterogeneous.
 bilateral rTMS was more effective than right rTMS in proportion of responders but equally
effective in remission rates in depressive episodes
 bilateral rTMS was more effective than right rTMS in proportion of responders but equally
The RoB of the primary papers was heterogeneous.
effective in remission rates in depressive episodes

The RoB of the primary papers was heterogeneous.
effective in remission rates in depressive episodes

The RoB of the primary papers was heterogeneous.
A sham-controlled RCT on adults with BD at a clinically remitted or non-acute state found that

The RoB of the primary papers was heterogeneous. 61, level I
A sham-controlled RCT on adults with BD at a clinically remitted or non-acute state found that
was more effective in improving verbal learning but not in areas of processing speed,
rTMS
A sham-controlled RCT on adults with BD at a clinically remitted or non-acute state found that

rTMS was more effective in improving verbal learning but not in areas of processing speed,
A sham-controlled RCT on adults with BD at a clinically remitted or non-acute state found that
attention, working memory, visual learning, reasoning and social cognition. In fact, there was
rTMS was more effective in improving verbal learning but not in areas of processing speed,
A sham-controlled RCT on adults with BD at a clinically remitted or non-acute state found that
attention, working memory, visual learning, reasoning and social cognition. In fact, there was
62, level I
no dyscognitive effect seen across subdomains.
rTMS was more effective in improving verbal learning but not in areas of processing speed,
attention, working memory, visual learning, reasoning and social cognition. In fact, there was
rTMS was more effective in improving verbal learning but not in areas of processing speed,
no dyscognitive effect seen across subdomains.
62, level I

attention, working memory, visual learning, reasoning and social cognition. In fact, there was
62, level I
no dyscognitive effect seen across subdomains.

attention, working memory, visual learning, reasoning and social cognition. In fact, there was
c.
Deep transcranial magnetic stimulation
no dyscognitive effect seen across subdomains.
62, level I

no dyscognitive effect seen across subdomains.
c.
Deep transcranial magnetic stimulation
62, level I
In the same systematic review as above, deep transcranial magnetic stimulation (TMS) was
c.
Deep transcranial magnetic stimulation
In the same systematic review as above, deep transcranial magnetic stimulation (TMS) was
more effective than sham treatment in reducing H
c.
Deep transcranial magnetic stimulation AM-D scores at end-point (four weeks) but
In the same systematic review as above, deep transcranial magnetic stimulation (TMS) was
c.
Deep transcranial magnetic stimulation AM-D scores at end-point (four weeks) but
more effective than sham treatment in reducing H
not at follow-up (eight weeks). There were no AEs reported.
In the same systematic review as above, deep transcranial magnetic stimulation (TMS) was
more effective than sham treatment in reducing HAM-D scores at end-point (four weeks) but
61, level I
not at follow-up (eight weeks). There were no AEs reported.
In the same systematic review as above, deep transcranial magnetic stimulation (TMS) was

more effective than sham treatment in reducing HAM-D scores at end-point (four weeks) but
not at follow-up (eight weeks). There were no AEs reported.
61, level I

more effective than sham treatment in reducing HAM-D scores at end-point (four weeks) but
not at follow-up (eight weeks). There were no AEs reported.polar depression found that deep
A sham-controlled RCT on adults with treatment-resistant bi
61, level I

61, level I
not at follow-up (eight weeks). There were no AEs reported.
A sham-controlled RCT on adults with treatment-resistant bipolar depression found that deep
TMS was more effective in improving depressive symptoms (based on HAM-D) but showed
A sham-controlled RCT on adults with treatment-resistant bipolar depression found that deep
TMS was more effective in improving depressive symptoms (based on HAM-D) but showed
NS difference in response rate, remission rate and cognitive measures at six weeks. There
A sham-controlled RCT on adults with treatment-resistant bipolar depression found that deep
TMS was more effective in improving depressive symptoms (based on HAM-D) but showed
A sham-controlled RCT on adults with treatment-resistant bipolar depression found that deep
NS difference in response rate, remission rate and cognitive measures at six weeks. There

63, level I
were no serious AEs.
TMS was more effective in improving depressive symptoms (based on HAM-D) but showed
NS difference in response rate, remission rate and cognitive measures at six weeks. There

63, level I
were no serious AEs.
TMS was more effective in improving depressive symptoms (based on HAM-D) but showed

NS difference in response rate, remission rate and cognitive measures at six weeks. There
63, level I
were no serious AEs.

NS difference in response rate, remission rate and cognitive measures at six weeks. There
Theta burst stimulation
d.
63, level I

were no serious AEs.

were no serious AEs.mulation
63, level I
Theta burst sti

d.
A systematic review on adults with BD found that theta burst stimulation (TBS) showed NS
Theta burst stimulation
d.
A systematic review on adults with BD found that theta burst stimulation (TBS) showed NS
difference in response and remission rates based on MADRS score compared with sham
Theta burst stimulation
d.
A systematic review on adults with BD found that theta burst stimulation (TBS) showed NS
Theta burst stimulation
d.
difference in response and remission rates based on MADRS score compared with sham
61, level I
treatment.

A systematic review on adults with BD found that theta burst stimulation (TBS) showed NS
difference in response and remission rates based on MADRS score compared with sham
treatment.
61, level I

A systematic review on adults with BD found that theta burst stimulation (TBS) showed NS

difference in response and remission rates based on MADRS score compared with sham

61, level I
treatment.

difference in response and remission rates based on MADRS score compared with sham

61, level I
A sham-controlled RCT on adults with bipolar depression with mixed features found that TBS
treatment.

treatment.
61, level I

A sham-controlled RCT on adults with bipolar depression with mixed features found that TBS
as an adjunct showed NS difference in effectiveness (response and remission rates based on
A sham-controlled RCT on adults with bipolar depression with mixed features found that TBS
as an adjunct showed NS difference in effectiveness (response and remission rates based on
MADRS scores) and safety.
64, level I

MADRS scores) and safety.

as an adjunct showed NS difference in effectiveness (response and remission rates based on
64, level I
MADRS scores) and safety.

as an adjunct showed NS difference in effectiveness (response and remission rates based on
Transcranial direct current stimulation
e.
64, level I
MADRS scores) and safety.

64, level I
Transcranial direct current stimulation
MADRS scores) and safety.
Transcranial direct current stimulation on adults with bipolar depression demonstrated:
e.
Transcranial direct current stimulation
Transcranial direct current stimulation on adults with bipolar depression demonstrated:
Transcranial direct current stimulation
e.  NS difference in response and remission rate compared with sham treatment in an 8-
Transcranial direct current stimulation on adults with bipolar depression demonstrated:
Transcranial direct current stimulation
e.  NS difference in response and remission rate compared with sham treatment in an 8-
Transcranial direct current stimulation on adults with bipolar depression demonstrated: blurred
week RCT and reported AEs included increased suicidality, headaches and
 NS difference in response and remission rate compared with sham treatment in an 8-
week RCT and reported AEs included increased suicidality, headaches and
Transcranial direct current stimulation on adults with bipolar depression demonstrated: blurred
vision
65, level I

 NS difference in response and remission rate compared with sham treatment in an 8-
week RCT and reported AEs included increased suicidality, headaches and blurred
vision
65, level I
 NS difference in response and remission rate compared with sham treatment in an 8-

 It was more effective as adjunct than sham treatment in response rate (NNT=2.69, 95%
week RCT and reported AEs included increased suicidality, headaches and blurred
65, level I
vision

week RCT and reported AEs included increased suicidality, headaches and blurred
 It was more effective as adjunct than sham treatment in response rate (NNT=2.69, 95%
65, level I
CI 1.84 to 4.
vision
99) and remission (NNT=5.46, 95% CI 3.38 to 14.2) in a 6-week RCT but
 It was more effective as adjunct than sham treatment in response rate (NNT=2.69, 95%
vision

65, level I
CI 1.84 to 4.99) and remission (NNT=5.46, 95% CI 3.38 to 14.2) in a 6-week RCT but
 It was more effective as adjunct than sham treatment in response rate (NNT=2.69, 95%
66, level I
with higher incidences of skin redness being reported

CI 1.84 to 4.99) and remission (NNT=5.46, 95% CI 3.38 to 14.2) in a 6-week RCT but
 It was more effective as adjunct than sham treatment in response rate (NNT=2.69, 95%
66, level I
with higher incidences of skin redness being reported

 NS difference in cognitive outcomes compared with sham treatment with no dyscognitive
CI 1.84 to 4.99) and remission (NNT=5.46, 95% CI 3.38 to 14.2) in a 6-week RCT but

with higher incidences of skin redness being reported
66, level I
CI 1.84 to 4.99) and remission (NNT=5.46, 95% CI 3.38 to 14.2) in a 6-week RCT but
 NS difference in cognitive outcomes compared with sham treatment with no dyscognitive
67, level I

effects reported
66, level I
with higher incidences of skin redness being reported

67, level I
with higher incidences of skin redness being reported
66, level I
effects reported

 NS difference in cognitive outcomes compared with sham treatment with no dyscognitive
 NS difference in cognitive outcomes compared with sham treatment with no dyscognitive
effects reported

67, level I
 NS difference in cognitive outcomes compared with sham treatment with no dyscognitive
effects reported
67, level I

effects reported 67, level I
17
17
17
17
17
17

26 27 28 29 30 31 32 33 34 35 36